Built on Experience

Medidata Is Founded

Fund manager Tarek Sherif moves into a small office with tech entrepreneur and researcher Glen de Vries, who hand-codes Medidata’s original software. Together with Ed Ikeguchi, they found Medidata.

EDC Launches

The first software to digitally collect clinical trial data. Later named Rave (Electronic Data Capture), it transforms data capture to become the world’s most advanced, robust, and secure system for managing clinical trial site, patient, and lab data.

Medidata Opens London Office

Medidata Opens Tokyo Office

Medidata NEXT Launches

A Rave best-practices forum, the Medidata User Group (MUG), becomes Medidata Symposium in 2015 and Medidata NEXT in 2017. Today, it convenes industry leaders and patient advocates to shape the future of life sciences.

Initial Public Offering on NASDAQ

Acquisition of Clinical Force

Adds Medidata CTMS® (Clinical Trial Management System) to solutions.

Acquisition of Mytrus

Adds eConsent to the Medidata Platform.

Acquisition of CHITA

Adds regulated content management and eTMF capabilities to the Medidata Platform.

Acquisition of SHYFT Analytics

Powers customers’ digital transformation with AI and real-world analytics.

Launches Medidata AI

Combines data, technology, and deep expertise to deliver actionable insights across the clinical development continuum—optimizing study execution and commercial success, and proving therapy value.

Dassault Systèmes Acquires Medidata

Dassault Systèmes, the 3DEXPERIENCE company, acquires Medidata to accelerate the digital transformation of life sciences —pushing the boundaries of innovation and learning to build a more sustainable future for patients and society.

Responding to COVID-19 with Data and Direction

Throughout 2020, Medidata publishes nine white papers analyzing COVID-19’s impact on drug and vaccine trials—assessing patient disruption and delivering data-driven guidance to help sponsors and CROs sustain and adapt studies worldwide.

Launches myMedidata

Built for and with patients, myMedidata is an award-winning portal enabling participants to learn, enroll, and engage in trials from any device—powering scalable, flexible, decentralized, and hybrid study models.

Powers Moderna’s COVID-19 Vaccine Trials

Medidata’s cloud platform enables the rapid advancement of Moderna’s mRNA-1273 program, supporting its 30,000-participant Phase 3 study with the scale, speed, and resilience required during the global pandemic.

Medidata Synthetic Control Arm® Supported by the FDA

In a regulatory first, the FDA permits Medicenna to use a hybrid external control arm in a Phase 3 registrational trial—building on a Phase 2 study in recurrent glioblastoma strengthened by Medidata’s Synthetic Control Arm®.

Launches myMedidata Registries

Expanding our patient portal to engage participants before enrollment and long after trial completion supports long-term follow-up and safety surveillance.

Introduces the First Unified Platform for DCTs

The industry’s first end-to-end, secure platform for decentralized clinical trials enables sponsors and CROs to manage drug, vaccine, and device studies seamlessly across the development continuum.

Launches Sensor Cloud and the Sensor Cloud Network

Delivering advanced data models and proprietary algorithms that rapidly ingest, normalize, and analyze patient-generated data accelerates decisions and timelines. The Sensor Cloud Network unites CROs, device makers, sponsors, analytics firms, and academia in the industry’s first cross-sector collaboration.

Rave Imaging Surpasses 1,000 Studies

Exceeding 1,000 supported trials, Rave Imaging processes more than 100 million images annually—scaling secure, cloud-based imaging management for global clinical research.

Remembering Glen de Vries

Glen set the highest standard for Medidata and championed our commitment to always innovate to solve our industry’s most complex problems. We will further Glen’s mission by continuing to push the boundaries of what’s possible.

Opens up Patient Insights Program

Enabling sponsors, CROs, and sites to embed patient perspectives directly into software design and improve the clinical research experience.

30,000 Trials, 9 Million Participants

The first life sciences technology company to surpass 30,000 trials and 9 million study volunteers.

Showcases Clinical Data Studio and Health Record Connect

New experiences for enhancing and streamlining clinical data workflows.

Anthony Costello Named CEO

Anthony Costello has advanced the use of technology in clinical trials for nearly 30 years. Across numerous leadership roles from entrepreneur to corporate c-suite, Anthony has transformed the patient, site, and sponsor experience, while accelerating the delivery of life-changing treatments.

Recognized for Site Innovation

Medidata was presented with the inaugural Site Innovation Award for its groundbreaking work in improving efficiency in clinical trials by the Summit for Clinical Ops Executives (SCOPE).

Global Rollout of Clinical Data Studio

Delivers a unified research experience with greater data quality control.

Launches Patient Payments

A new solution for streamlining trial-related stipends and reimbursements for patients participating in clinical research.

Introduces Rave Lite

An extension of its gold-standard clinical research software, Rave, and designed explicitly for Phase I and IV studies.

Enters CNS Space with Cogstate Partnership

A partnership with neuroscience solutions leader Cogstate reshapes clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders.

35,000 Trials,10 Million Participants

Surpasses 35,000 trials and 10 million study volunteers worldwide.

Integrates UK Health Costing Data

First to integrate UK-mandated Health Costing Data into its financial management portfolio.

Another Milestone

Surpasses 36,000 Clinical Trials and 11 Million Participants

Launches Site Insights Program

Elevating the Site Voice and strengthening site partnership and performance in clinical trials.

Launches Protocol Optimization

Unveils Protocol Optimization at ASCO, advancing data-driven study design and execution.